Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children
10.1038/s41598-019-51137-5
Saved in:
Main Authors: | Yung, C.F., Ma, X., Cheung, Y.B., Oh, B.K., Soh, S., Thoon, K.C. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
Nature Publishing Group
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/212241 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Kawasaki disease following administration of 13-valent pneumococcal conjugate vaccine in young children
by: Yung, Chee Fu, et al.
Published: (2020) -
Author Correction: Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children (Scientific Reports, (2019), 9, 1, (14705), 10.1038/s41598-019-51137-5)
by: Yung, Chee Fu, et al.
Published: (2022) -
Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster
by: Russell, F.M., et al.
Published: (2014) -
Pneumococcal infection among children before introduction of 13-valent pneumococcal conjugate vaccine, Cambodia
by: Paul Turner, et al.
Published: (2018) -
A cost-effectiveness analysis of the 13-valent pneumococcal conjugated vaccine and the 23-valent pneumococcal polysaccharide vaccine among Thai older adult
by: Ngamprasertchai T.
Published: (2023)